This reads like a doom & gloom article. Better judge these articles by their slant. How many good news do they cover? There of course are those even during Cov

This reads like a doom & gloom article. Better judge these articles by their slant. How many good news do they cover? There of course are those even during Covid-19 times. However, this one actively tries to drive its point home with blinders on. Amusingly, the author's tag line is "I provide a bird's eye view of what's driving the markets". He is not. Pfizer is not the only company in the world trying here. Three days ago, Astra Zeneca reported about a vaccine triggering a similar immune response among young and old adults. They also reported lower adverse reactions to the vaccine among elderly. Astra Zeneca shares took a little jump at the news. https://www.cnbc.com/2020/10/26/oxford-astrazeneca-coronavirus-vaccine-reportedly-triggers-immune-response-among-adults-.html https://www.cnbc.com/2020/10/26/oxford-astrazeneca-coronavir... So why is he cherry picking Pfizer? The ECB has recently announced they have further stimulus artillery ready if the need comes. So why is he trying to sow doubt? Is this article intended to cover only domestic news or the bird's eye view of the globalized economy? He can't just pick and choose if he wants to analyze. He's explaining how the SAP stock crash is spreading ripples to e.g. Oracle, IBM, Microsoft, Adobe when all these -- barring IBM maybe -- are much, much better off today than during the pandemic's earlier days. Post-SAP crash. Obviously they were affected by we have little to no stock market data yet.